Related references
Note: Only part of the references are listed.The Plasma NAD+ Metabolome Is Dysregulated in Normal Aging
James Clement et al.
REJUVENATION RESEARCH (2019)
Lack of -amyloid cleaving enzyme-1 (BACE1) impairs long-term synaptic plasticity but enhances granule cell excitability and oscillatory activity in the dentate gyrus in vivo
Matej Vnencak et al.
BRAIN STRUCTURE & FUNCTION (2019)
Multi-target-directed triazole derivatives as promising agents for the treatment of Alzheimer's disease
Anupamjeet Kaur et al.
BIOORGANIC CHEMISTRY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease
Zhipei Sang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Hippocampal neurons in direct contact with astrocytes exposed to amyloid β25-35 exhibit reduced excitatory synaptic transmission
Kohei Oyabu et al.
IBRO REPORTS (2019)
Quantifying the cellular NAD plus metabolome using a tandem liquid chromatography mass spectrometry approach
Sonia Bustamante et al.
METABOLOMICS (2018)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
Steve P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Metals and Alzheimer's Disease: How Far Have We Come in the Clinic?
Paul A. Adlard et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Nicotinamide adenine dinucleotide and its related precursors for the treatment of Alzheimer's disease
Nady Braidy et al.
CURRENT OPINION IN PSYCHIATRY (2018)
A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's disease
Duraippandi Palanimuthu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease
Minna Oksanen et al.
STEM CELL REPORTS (2017)
Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1)
Benjamin A. Harlan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds
Michael S. Bonkowski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein
Saoussen Ben Halima et al.
CELL REPORTS (2016)
NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
Carles Canto et al.
CELL METABOLISM (2015)
LC-UV/MS methods for the analysis of prochelator-Boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH)
Jan Bures et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
NAD+ in aging, metabolism, and neurodegeneration
Eric Verdin
SCIENCE (2015)
Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents
Vit Sestak et al.
ONCOTARGET (2015)
In vitro streptozotocin model for modeling Alzheimer-like changes: effect on amyloid precursor protein secretases and glycogen synthase kinase-3
Konstanze Plaschke et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
A Method for Evaluating the Level of Soluble β-Amyloid(1-40/1-42) in Alzheimer's Disease Based on the Binding of Gelsolin to β-Amyloid Peptides
Yanyan Yu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Mapping NAD+ metabolism in the brain of ageing Wistar rats: potential targets for influencing brain senescence
Nady Braidy et al.
BIOGERONTOLOGY (2014)
Sirtuins: Nodes Connecting Aging, Metabolism and Tumorigenesis
Yisha Yao et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Aβ peptide aggregation
Luiza M. F. Gomes et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
The C. elegans lifespan assay toolkit
Francis Raj Gandhi Amrit et al.
METHODS (2014)
Potent Antimycobacterial Activity of the Pyridoxal Isonicotinoyl Hydrazone Analog 2-Pyridylcarboxaldehyde Isonicotinoyl Hydrazone: A Lipophilic Transport Vehicle for Isonicotinic Acid Hydrazide
Samantha Ellis et al.
MOLECULAR PHARMACOLOGY (2014)
Metal dyshomeostasis and oxidative stress in Alzheimer's disease
Mark A. Greenough et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
TARGETED, LCMS-BASED METABOLOMICS FOR QUANTITATIVE MEASUREMENT OF NAD+METABOLITES
Samuel A. J. Trammell et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2013)
Copper and Oxidative Stress in the Pathogenesis of Alzheimer's Disease
Goezde Eskici et al.
BIOCHEMISTRY (2012)
Dual-function triazole-pyridine derivatives as inhibitors of metal-induced amyloid-beta aggregation
Michael R. Jones et al.
METALLOMICS (2012)
β-amyloid activates PARP causing astrocytic metabolic failure and neuronal death
Rosella Abeti et al.
BRAIN (2011)
Age Related Changes in NAD plus Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats (Publication with Expression of Concern. See vol. 17, 2022)
Nady Braidy et al.
PLOS ONE (2011)
An Overview of APP Processing Enzymes and Products
Vivian W. Chow et al.
NEUROMOLECULAR MEDICINE (2010)
Structure-activity relationships of novel iron Chelators for the treatment of iron overload disease: The methyl pyrazinylketone isonicotinoyl hydrazone series
Danuta S. Kalinowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class
C. K. Lim et al.
MOLECULAR PHARMACOLOGY (2008)
Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery
Javed A. Khan et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Structure-brain exposure relationships
Stephen A. Hitchcock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity
Des R. Richardson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Poly(ADP-ribose):: novel functions for an old molecule
Valerie Schreiber et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
The evolution of iron chelators for the treatment of iron overload disease and cancer
DS Kalinowski et al.
PHARMACOLOGICAL REVIEWS (2005)
Alzheimer's disease:: Aβ, tau and synaptic dysfunction
FM LaFerla et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Direct quantitation of poly(ADP-Ribose) polymerase (PARP) activity as a means to distinguish necrotic and apoptotic death in cell and tissue samples
KS Putt et al.
CHEMBIOCHEM (2005)
Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment
J Yuan et al.
BLOOD (2004)
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
JG Wood et al.
NATURE (2004)
High throughput artificial membrane permeability assay for blood-brain barrier
L Di et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease - A pilot phase 2 clinical trial
CW Ritchie et al.
ARCHIVES OF NEUROLOGY (2003)
An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript
JT Rogers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
GJ Guillemin et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Share Paper
